Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Implanet S.A.

IMPZYPNK
Healthcare
Medical - Devices
$0.08
$0.00(0.00%)
U.S. Market opens in 14h 45m

Implanet S.A. Fundamental Analysis

Implanet S.A. (IMPZY) shows moderate financial fundamentals with a PE ratio of -35.19, profit margin of -43.36%, and ROE of 15.11%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

Operating Margin-43.18%
Cash Position0.25%
PEG Ratio10.25
Current Ratio0.72
We analyze IMPZY's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 63.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
63.8/100

We analyze IMPZY's fundamental strength across five key dimensions:

Efficiency Score

Weak

IMPZY struggles to generate sufficient returns from assets.

ROA > 10%
-29.11%

Valuation Score

Moderate

IMPZY shows balanced valuation metrics.

PE < 25
-35.19
PEG Ratio < 2
10.25

Growth Score

Weak

IMPZY faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

IMPZY shows balanced financial health with some risks.

Debt/Equity < 1
-4.49
Current Ratio > 1
0.72

Profitability Score

Weak

IMPZY struggles to sustain strong margins.

ROE > 15%
15.11%
Net Margin ≥ 15%
-43.36%
Positive Free Cash Flow
No

Key Financial Metrics

Is IMPZY Expensive or Cheap?

P/E Ratio

IMPZY trades at -35.19 times earnings. This suggests potential undervaluation.

-35.19

PEG Ratio

When adjusting for growth, IMPZY's PEG of 10.25 indicates potential overvaluation.

10.25

Price to Book

The market values Implanet S.A. at -124.13 times its book value. This may indicate undervaluation.

-124.13

EV/EBITDA

Enterprise value stands at -47.15 times EBITDA. This is generally considered low.

-47.15

How Well Does IMPZY Make Money?

Net Profit Margin

For every $100 in sales, Implanet S.A. keeps $-43.36 as profit after all expenses.

-43.36%

Operating Margin

Core operations generate -43.18 in profit for every $100 in revenue, before interest and taxes.

-43.18%

ROE

Management delivers $15.11 in profit for every $100 of shareholder equity.

15.11%

ROA

Implanet S.A. generates $-29.11 in profit for every $100 in assets, demonstrating efficient asset deployment.

-29.11%

Following the Money - Real Cash Generation

Operating Cash Flow

Implanet S.A. generates limited operating cash flow of $-280.19K, signaling weaker underlying cash strength.

$-280.19K

Free Cash Flow

Implanet S.A. generates weak or negative free cash flow of $-1.23M, restricting financial flexibility.

$-1.23M

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

IMPZY converts -0.72% of its market value into free cash.

-0.72%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-35.19

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

10.25

vs 25 benchmark

P/B Ratio

Price to book value ratio

-124.13

vs 25 benchmark

P/S Ratio

Price to sales ratio

15.32

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-4.49

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.72

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

15.11

vs 25 benchmark

ROA

Return on assets percentage

-0.29

vs 25 benchmark

ROCE

Return on capital employed

-76.06

vs 25 benchmark

How IMPZY Stacks Against Its Sector Peers

MetricIMPZY ValueSector AveragePerformance
P/E Ratio-35.1929.45 Better (Cheaper)
ROE1510.83%779.00% Excellent
Net Margin-43.36%-24930.00% (disorted) Weak
Debt/Equity-4.490.26 Strong (Low Leverage)
Current Ratio0.724.65 Weak Liquidity
ROA-29.11%-19333.00% (disorted) Weak

IMPZY outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Implanet S.A.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ